Clarivate sells Life Sciences unit to Altaris for $600M
Clarivate announced it is divesting its Life Sciences & Healthcare segment to Altaris LLC for $600 million. The deal aims to sharpen focus on AI-driven segments and improve financial flexibility.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day